These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

196 related items for PubMed ID: 34662550

  • 1. The pro-proliferative effect of interferon-γ in breast cancer cell lines is dependent on stimulation of ASCT2-mediated glutamine cellular uptake.
    Silva C, Andrade N, Rodrigues I, Ferreira AC, Soares ML, Martel F.
    Life Sci; 2021 Dec 01; 286():120054. PubMed ID: 34662550
    [Abstract] [Full Text] [Related]

  • 2. Glutamine-β-cyclodextrin for targeted doxorubicin delivery to triple-negative breast cancer tumors via the transporter ASCT2.
    Zhou P, Liang X, Zhou C, Qin J, Hou C, Zhu Z, Zhang W, Wang S, Zhong D.
    J Mater Chem B; 2019 Sep 11; 7(35):5363-5375. PubMed ID: 31403158
    [Abstract] [Full Text] [Related]

  • 3. Lobetyolin inhibits the proliferation of breast cancer cells via ASCT2 down-regulation-induced apoptosis.
    Chen Y, Tian Y, Jin G, Cui Z, Guo W, Zhang X, Liu X.
    Hum Exp Toxicol; 2021 Dec 11; 40(12):2074-2086. PubMed ID: 34075790
    [Abstract] [Full Text] [Related]

  • 4. ASCT2/SLC1A5 controls glutamine uptake and tumour growth in triple-negative basal-like breast cancer.
    van Geldermalsen M, Wang Q, Nagarajah R, Marshall AD, Thoeng A, Gao D, Ritchie W, Feng Y, Bailey CG, Deng N, Harvey K, Beith JM, Selinger CI, O'Toole SA, Rasko JE, Holst J.
    Oncogene; 2016 Jun 16; 35(24):3201-8. PubMed ID: 26455325
    [Abstract] [Full Text] [Related]

  • 5. Topotecan induces apoptosis via ASCT2 mediated oxidative stress in gastric cancer.
    Wang L, Liu Y, Zhao TL, Li ZZ, He JY, Zhang BJ, Du HZ, Jiang JW, Yuan ST, Sun L.
    Phytomedicine; 2019 Apr 16; 57():117-128. PubMed ID: 30668314
    [Abstract] [Full Text] [Related]

  • 6. Inhibition of Glutamine Cellular Uptake Contributes to the Cytotoxic Effect of Xanthohumol in Triple-Negative Breast Cancer Cells.
    Carmo F, Silva C, Martel F.
    Nutr Cancer; 2022 Apr 16; 74(9):3413-3430. PubMed ID: 35594207
    [Abstract] [Full Text] [Related]

  • 7. Tamoxifen and raloxifene suppress the proliferation of estrogen receptor-negative cells through inhibition of glutamine uptake.
    Todorova VK, Kaufmann Y, Luo S, Klimberg VS.
    Cancer Chemother Pharmacol; 2011 Feb 16; 67(2):285-91. PubMed ID: 20383709
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. ASCT2 (SLC1A5)-dependent glutamine uptake is involved in the progression of head and neck squamous cell carcinoma.
    Zhang Z, Liu R, Shuai Y, Huang Y, Jin R, Wang X, Luo J.
    Br J Cancer; 2020 Jan 16; 122(1):82-93. PubMed ID: 31819178
    [Abstract] [Full Text] [Related]

  • 10. Topotecan induces hepatocellular injury via ASCT2 mediated oxidative stress.
    Zhou G, Qin M, Zhang X, Yang J, Yu H.
    Gastroenterol Hepatol; 2021 Jan 16; 44(1):1-12. PubMed ID: 33039171
    [Abstract] [Full Text] [Related]

  • 11. Targeting ASCT2-mediated glutamine metabolism inhibits proliferation and promotes apoptosis of pancreatic cancer cells.
    Wang W, Pan H, Ren F, Chen H, Ren P.
    Biosci Rep; 2022 Mar 31; 42(3):. PubMed ID: 35237783
    [Abstract] [Full Text] [Related]

  • 12. ASCT2 (SLC1A5) is an EGFR-associated protein that can be co-targeted by cetuximab to sensitize cancer cells to ROS-induced apoptosis.
    Lu H, Li X, Lu Y, Qiu S, Fan Z.
    Cancer Lett; 2016 Oct 10; 381(1):23-30. PubMed ID: 27450723
    [Abstract] [Full Text] [Related]

  • 13. Dependence on glutamine uptake and glutamine addiction characterize myeloma cells: a new attractive target.
    Bolzoni M, Chiu M, Accardi F, Vescovini R, Airoldi I, Storti P, Todoerti K, Agnelli L, Missale G, Andreoli R, Bianchi MG, Allegri M, Barilli A, Nicolini F, Cavalli A, Costa F, Marchica V, Toscani D, Mancini C, Martella E, Dall'Asta V, Donofrio G, Aversa F, Bussolati O, Giuliani N.
    Blood; 2016 Aug 04; 128(5):667-79. PubMed ID: 27268090
    [Abstract] [Full Text] [Related]

  • 14. ASCT2 is a major contributor to serine uptake in cancer cells.
    Conger KO, Chidley C, Ozgurses ME, Zhao H, Kim Y, Semina SE, Burns P, Rawat V, Lietuvninkas L, Sheldon R, Ben-Sahra I, Frasor J, Sorger PK, DeNicola GM, Coloff JL.
    Cell Rep; 2024 Aug 27; 43(8):114552. PubMed ID: 39068660
    [Abstract] [Full Text] [Related]

  • 15. In human entrocytes, GLN transport and ASCT2 surface expression induced by short-term EGF are MAPK, PI3K, and Rho-dependent.
    Avissar NE, Sax HC, Toia L.
    Dig Dis Sci; 2008 Aug 27; 53(8):2113-25. PubMed ID: 18157695
    [Abstract] [Full Text] [Related]

  • 16. The glutamine transporter ASCT2 (SLC1A5) promotes tumor growth independently of the amino acid transporter LAT1 (SLC7A5).
    Cormerais Y, Massard PA, Vucetic M, Giuliano S, Tambutté E, Durivault J, Vial V, Endou H, Wempe MF, Parks SK, Pouyssegur J.
    J Biol Chem; 2018 Feb 23; 293(8):2877-2887. PubMed ID: 29326164
    [Abstract] [Full Text] [Related]

  • 17. Luminal leptin inhibits L-glutamine transport in rat small intestine: involvement of ASCT2 and B0AT1.
    Ducroc R, Sakar Y, Fanjul C, Barber A, Bado A, Lostao MP.
    Am J Physiol Gastrointest Liver Physiol; 2010 Jul 23; 299(1):G179-85. PubMed ID: 20448142
    [Abstract] [Full Text] [Related]

  • 18. ASCT2 overexpression is associated with poor survival of OSCC patients and ASCT2 knockdown inhibited growth of glutamine-addicted OSCC cells.
    Luo Y, Li W, Ling Z, Hu Q, Fan Z, Cheng B, Tao X.
    Cancer Med; 2020 May 23; 9(10):3489-3499. PubMed ID: 32162845
    [Abstract] [Full Text] [Related]

  • 19. Neddylation inhibition induces glutamine uptake and metabolism by targeting CRL3SPOP E3 ligase in cancer cells.
    Zhou Q, Lin W, Wang C, Sun F, Ju S, Chen Q, Wang Y, Chen Y, Li H, Wang L, Hu Z, Jin H, Wang X, Sun Y.
    Nat Commun; 2022 May 31; 13(1):3034. PubMed ID: 35641493
    [Abstract] [Full Text] [Related]

  • 20. Glutamine transport in C6 glioma cells: substrate specificity and modulation in a glutamine deprived culture medium.
    Dolińska M, Dybel A, Hilgier W, Zielińska M, Zabłocka B, Buzańska L, Albrecht J.
    J Neurosci Res; 2001 Dec 01; 66(5):959-66. PubMed ID: 11746424
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 10.